vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Community Healthcare Trust Inc (CHCT). Click either name above to swap in a different company.
Community Healthcare Trust Inc is the larger business by last-quarter revenue ($31.5M vs $19.2M, roughly 1.6× Apyx Medical Corp). Community Healthcare Trust Inc runs the higher net margin — 8.1% vs -6.8%, a 14.9% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 4.8%). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 7.0%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
APYX vs CHCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $31.5M |
| Net Profit | $-1.3M | $2.5M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | — |
| Net Margin | -6.8% | 8.1% |
| Revenue YoY | 34.7% | 4.8% |
| Net Profit YoY | 71.9% | 60.2% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $31.5M | ||
| Q4 25 | $19.2M | $30.9M | ||
| Q3 25 | $12.9M | $31.1M | ||
| Q2 25 | $11.4M | $29.1M | ||
| Q1 25 | $9.4M | $30.1M | ||
| Q4 24 | $14.2M | $29.3M | ||
| Q3 24 | $11.5M | $29.6M | ||
| Q2 24 | $12.1M | $27.5M |
| Q1 26 | — | $2.5M | ||
| Q4 25 | $-1.3M | $14.4M | ||
| Q3 25 | $-2.0M | $1.6M | ||
| Q2 25 | $-3.8M | $-12.6M | ||
| Q1 25 | $-4.2M | $1.6M | ||
| Q4 24 | $-4.6M | $1.8M | ||
| Q3 24 | $-4.7M | $1.7M | ||
| Q2 24 | $-6.6M | $-10.4M |
| Q1 26 | — | — | ||
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | -6.5% | — | ||
| Q2 25 | -22.6% | — | ||
| Q1 25 | -32.4% | — | ||
| Q4 24 | -21.4% | — | ||
| Q3 24 | -31.6% | — | ||
| Q2 24 | -45.7% | — |
| Q1 26 | — | 8.1% | ||
| Q4 25 | -6.8% | 46.6% | ||
| Q3 25 | -15.4% | 5.3% | ||
| Q2 25 | -33.2% | -43.2% | ||
| Q1 25 | -44.0% | 5.3% | ||
| Q4 24 | -32.5% | 6.3% | ||
| Q3 24 | -40.9% | 5.9% | ||
| Q2 24 | -54.0% | -37.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.52 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $-0.50 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.04 | ||
| Q3 24 | — | $0.04 | ||
| Q2 24 | $-0.19 | $-0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $2.6M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $421.3M |
| Total Assets | $66.8M | $1.0B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.6M | ||
| Q4 25 | $31.7M | $3.3M | ||
| Q3 25 | $25.1M | $3.4M | ||
| Q2 25 | $29.3M | $4.9M | ||
| Q1 25 | $31.0M | $2.3M | ||
| Q4 24 | $31.7M | $4.4M | ||
| Q3 24 | $28.0M | $2.8M | ||
| Q2 24 | $32.7M | $734.0K |
| Q1 26 | — | — | ||
| Q4 25 | $37.5M | $532.2M | ||
| Q3 25 | $37.5M | $530.1M | ||
| Q2 25 | $37.5M | $500.1M | ||
| Q1 25 | $37.5M | $496.0M | ||
| Q4 24 | $37.5M | $486.0M | ||
| Q3 24 | $37.5M | $473.7M | ||
| Q2 24 | — | $457.6M |
| Q1 26 | — | $421.3M | ||
| Q4 25 | $14.5M | $429.4M | ||
| Q3 25 | $5.8M | $426.8M | ||
| Q2 25 | $7.3M | $437.8M | ||
| Q1 25 | $10.5M | $461.3M | ||
| Q4 24 | $14.2M | $476.0M | ||
| Q3 24 | $11.0M | $477.2M | ||
| Q2 24 | $14.7M | $497.8M |
| Q1 26 | — | $1.0B | ||
| Q4 25 | $66.8M | $990.8M | ||
| Q3 25 | $57.4M | $987.3M | ||
| Q2 25 | $58.2M | $966.3M | ||
| Q1 25 | $60.2M | $985.1M | ||
| Q4 24 | $64.8M | $992.6M | ||
| Q3 24 | $60.7M | $981.8M | ||
| Q2 24 | $65.4M | $983.2M |
| Q1 26 | — | — | ||
| Q4 25 | 2.58× | 1.24× | ||
| Q3 25 | 6.41× | 1.24× | ||
| Q2 25 | 5.17× | 1.14× | ||
| Q1 25 | 3.57× | 1.08× | ||
| Q4 24 | 2.64× | 1.02× | ||
| Q3 24 | 3.40× | 0.99× | ||
| Q2 24 | — | 0.92× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | — |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -14.6% | — |
| Capex IntensityCapex / Revenue | 1.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.5M | $56.4M | ||
| Q3 25 | $-3.5M | $12.7M | ||
| Q2 25 | $-1.2M | $13.8M | ||
| Q1 25 | $-702.0K | $14.4M | ||
| Q4 24 | $-2.9M | $58.9M | ||
| Q3 24 | $-4.4M | $13.8M | ||
| Q2 24 | $-4.3M | $16.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-2.8M | $35.9M | ||
| Q3 25 | $-4.1M | $7.6M | ||
| Q2 25 | $-1.5M | $9.6M | ||
| Q1 25 | $-757.0K | $9.7M | ||
| Q4 24 | $-3.2M | $34.2M | ||
| Q3 24 | $-4.6M | $6.7M | ||
| Q2 24 | $-4.6M | $9.5M |
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | 116.0% | ||
| Q3 25 | -31.5% | 24.6% | ||
| Q2 25 | -13.2% | 32.9% | ||
| Q1 25 | -8.0% | 32.3% | ||
| Q4 24 | -22.4% | 116.9% | ||
| Q3 24 | -40.0% | 22.5% | ||
| Q2 24 | -38.0% | 34.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | 66.3% | ||
| Q3 25 | 4.0% | 16.3% | ||
| Q2 25 | 2.3% | 14.5% | ||
| Q1 25 | 0.6% | 15.6% | ||
| Q4 24 | 1.7% | 84.1% | ||
| Q3 24 | 1.3% | 24.2% | ||
| Q2 24 | 2.4% | 26.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.91× | ||
| Q3 25 | — | 7.76× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.06× | ||
| Q4 24 | — | 32.14× | ||
| Q3 24 | — | 7.92× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
